Share Price and Basic Stock Data
Last Updated: November 26, 2025, 6:23 pm
| PEG Ratio | 0.95 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Univastu India Ltd operates in the Construction, Contracting & Engineering sector, with its stock currently priced at ₹65.6 and a market capitalization of ₹236 Cr. The company has shown notable revenue growth over the years, with reported sales rising from ₹59 Cr in FY 2022 to ₹87 Cr in FY 2023, and further projected to reach ₹121 Cr in FY 2024 and ₹171 Cr in FY 2025. This trend indicates a robust compound annual growth rate, reflecting strong demand and operational capabilities. Quarterly sales figures also depict fluctuations; for instance, sales peaked at ₹28.04 Cr in December 2022, before dipping to ₹24.53 Cr in September 2023, before recovering to ₹29.93 Cr in December 2023. The consistent sales growth positions Univastu favorably against competitors in the construction sector, where typical annual revenue growth can range between 10% to 20% based on industry analysis.
Profitability and Efficiency Metrics
Univastu has demonstrated solid profitability metrics, with a reported net profit of ₹18 Cr and a net profit margin of 9.06% for FY 2025. The company’s operating profit margin (OPM) stood at 24.92%, indicating efficient cost management relative to its sales. Profit before tax for FY 2025 recorded at ₹23 Cr, while the return on equity (ROE) was 15.8%, showcasing effective utilization of shareholder funds. Efficiency ratios highlight a cash conversion cycle (CCC) of -110 days, which is significantly lower than the industry average, suggesting superior operational efficiency in converting inventory into cash. Additionally, the interest coverage ratio (ICR) of 6.81x indicates that the company comfortably meets its interest obligations, a positive sign for investors and creditors alike.
Balance Sheet Strength and Financial Ratios
Univastu’s balance sheet reflects a conservative capital structure with no reported borrowings, which is atypical in the construction sector where leverage is commonly employed. The company’s total debt to equity ratio stood at 0.43, indicating a relatively low reliance on debt financing. The book value per share grew significantly from ₹34.04 in FY 2022 to ₹66.70 in FY 2025, underscoring the company’s enhanced asset base and shareholder equity. Financial ratios such as the current ratio of 1.73 and quick ratio of 1.71 suggest adequate liquidity to meet short-term obligations. Furthermore, the price-to-book value (P/BV) ratio of 3.19x is higher than the sector average, reflecting market confidence in the company’s growth potential and profitability. However, despite the strength in the balance sheet, the absence of reserves could be a concern for future investment opportunities.
Shareholding Pattern and Investor Confidence
The shareholding structure of Univastu India Ltd is predominantly held by promoters, who own 67.46% of the company as of June 2025. This high promoter holding can instill confidence in investors regarding the management’s commitment to the company’s long-term success. The public shareholding has increased to 32.54%, indicating a growing interest from retail investors, with the number of shareholders rising to 7,104. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may limit larger scale investments and confidence from institutional players. The declining promoter share from 73.47% in March 2023 to 67.46% in June 2025 raises questions about potential dilution of control, which could affect strategic decision-making. Overall, while promoter confidence is strong, the lack of institutional backing may pose challenges for future fundraising initiatives.
Outlook, Risks, and Final Insight
Looking ahead, Univastu India Ltd appears poised for continued growth, driven by its operational efficiency and strong financial metrics. However, risks remain, including the potential for fluctuating raw material costs and market competition, which could impact profit margins. Additionally, the company’s reliance on a limited number of projects could expose it to revenue volatility should any significant contracts face delays or cancellations. The lack of reserves also raises questions about financial flexibility in times of need. In a favorable scenario, if the construction sector remains buoyant, Univastu could leverage its strong operational metrics to expand its market share. Conversely, adverse economic conditions could hinder growth and profitability, necessitating a cautious approach from investors. Overall, Univastu’s strengths in profitability and operational efficiency provide a solid foundation, but awareness of potential risks is crucial for stakeholders.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Univastu India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modis Navnirman Ltd | 728 Cr. | 370 | 409/220 | 88.8 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 162 Cr. | 23.5 | 35.7/18.0 | 44.7 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 34.7 Cr. | 46.9 | 92.7/38.0 | 127 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 29.1 Cr. | 58.3 | 78.1/47.1 | 2.12 | 0.00 % | 16.6 % | % | 10.0 | |
| HB Estate Developers Ltd | 181 Cr. | 79.0 | 122/69.9 | 16.4 | 81.0 | 0.00 % | 8.20 % | 6.60 % | 10.0 |
| Industry Average | 16,994.81 Cr | 254.16 | 91.06 | 139.95 | 0.15% | 16.62% | 21.24% | 21.58 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.94 | 17.55 | 28.04 | 28.01 | 26.78 | 24.53 | 29.93 | 39.25 | 28.11 | 42.39 | 41.99 | 39.91 | 29.41 |
| Expenses | 10.26 | 13.28 | 22.45 | 25.47 | 23.82 | 20.44 | 25.21 | 30.89 | 23.51 | 33.90 | 34.26 | 32.16 | 22.08 |
| Operating Profit | 2.68 | 4.27 | 5.59 | 2.54 | 2.96 | 4.09 | 4.72 | 8.36 | 4.60 | 8.49 | 7.73 | 7.75 | 7.33 |
| OPM % | 20.71% | 24.33% | 19.94% | 9.07% | 11.05% | 16.67% | 15.77% | 21.30% | 16.36% | 20.03% | 18.41% | 19.42% | 24.92% |
| Other Income | 0.04 | 0.09 | 0.12 | 0.16 | 0.43 | 0.72 | 0.10 | 0.09 | 0.11 | 0.10 | 0.15 | 0.49 | 0.17 |
| Interest | 1.15 | 1.44 | 1.43 | 1.61 | 1.48 | 1.59 | 1.14 | 1.22 | 1.01 | 1.05 | 1.20 | 1.02 | 1.09 |
| Depreciation | 0.23 | 0.22 | 0.22 | 0.22 | 0.23 | 0.33 | 0.28 | 0.40 | 0.28 | 0.29 | 0.40 | 0.41 | 0.41 |
| Profit before tax | 1.34 | 2.70 | 4.06 | 0.87 | 1.68 | 2.89 | 3.40 | 6.83 | 3.42 | 7.25 | 6.28 | 6.81 | 6.00 |
| Tax % | 25.37% | 25.19% | 25.37% | 35.63% | 27.38% | 34.26% | 27.06% | 32.94% | 28.36% | 44.41% | 18.95% | 38.18% | 33.17% |
| Net Profit | 1.01 | 2.02 | 3.02 | 0.56 | 1.22 | 1.90 | 2.49 | 4.58 | 2.45 | 4.05 | 5.08 | 4.22 | 4.01 |
| EPS in Rs | 0.89 | 1.78 | 2.66 | 0.49 | 0.88 | 1.31 | 1.37 | 2.88 | 1.53 | 2.71 | 2.67 | 2.34 | 2.18 |
Last Updated: August 20, 2025, 1:45 am
Below is a detailed analysis of the quarterly data for Univastu India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 29.41 Cr.. The value appears to be declining and may need further review. It has decreased from 39.91 Cr. (Mar 2025) to 29.41 Cr., marking a decrease of 10.50 Cr..
- For Expenses, as of Jun 2025, the value is 22.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 32.16 Cr. (Mar 2025) to 22.08 Cr., marking a decrease of 10.08 Cr..
- For Operating Profit, as of Jun 2025, the value is 7.33 Cr.. The value appears to be declining and may need further review. It has decreased from 7.75 Cr. (Mar 2025) to 7.33 Cr., marking a decrease of 0.42 Cr..
- For OPM %, as of Jun 2025, the value is 24.92%. The value appears strong and on an upward trend. It has increased from 19.42% (Mar 2025) to 24.92%, marking an increase of 5.50%.
- For Other Income, as of Jun 2025, the value is 0.17 Cr.. The value appears to be declining and may need further review. It has decreased from 0.49 Cr. (Mar 2025) to 0.17 Cr., marking a decrease of 0.32 Cr..
- For Interest, as of Jun 2025, the value is 1.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.02 Cr. (Mar 2025) to 1.09 Cr., marking an increase of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 0.41 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.41 Cr..
- For Profit before tax, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.81 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 0.81 Cr..
- For Tax %, as of Jun 2025, the value is 33.17%. The value appears to be improving (decreasing) as expected. It has decreased from 38.18% (Mar 2025) to 33.17%, marking a decrease of 5.01%.
- For Net Profit, as of Jun 2025, the value is 4.01 Cr.. The value appears to be declining and may need further review. It has decreased from 4.22 Cr. (Mar 2025) to 4.01 Cr., marking a decrease of 0.21 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.18. The value appears to be declining and may need further review. It has decreased from 2.34 (Mar 2025) to 2.18, marking a decrease of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:13 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 42 | 82 | 101 | 111 | 51 | 59 | 87 | 121 | 171 | 160 |
| Expenses | 19 | 38 | 75 | 90 | 100 | 30 | 46 | 72 | 101 | 143 | 129 |
| Operating Profit | 3 | 4 | 6 | 11 | 11 | 21 | 13 | 15 | 20 | 28 | 31 |
| OPM % | 13% | 9% | 8% | 11% | 10% | 42% | 22% | 17% | 16% | 17% | 19% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 4 | 4 | 7 | 5 | 5 | 5 | 4 | 4 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 1 | 2 | 5 | 6 | 6 | 13 | 7 | 9 | 15 | 23 | 26 |
| Tax % | 40% | 28% | 29% | 27% | 25% | 27% | 27% | 26% | 32% | 34% | |
| Net Profit | 1 | 1 | 3 | 5 | 4 | 10 | 5 | 7 | 10 | 16 | 18 |
| EPS in Rs | 1.02 | 0.54 | 0.98 | 1.33 | 1.27 | 2.81 | 1.54 | 1.94 | 2.09 | 2.91 | 3.68 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 200.00% | 66.67% | -20.00% | 150.00% | -50.00% | 40.00% | 42.86% | 60.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 200.00% | -133.33% | -86.67% | 170.00% | -200.00% | 90.00% | 2.86% | 17.14% |
Univastu India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 43% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 26% |
| TTM: | 43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 51% |
| 3 Years: | 49% |
| 1 Year: | 40% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 15% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:50 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 129 | 81 | 130 | 112 | 43 | 471 | 173 | 77 | 39 | 15 |
| Inventory Days | 210 | 116 | 141 | 274 | 0 | 0 | 0 | 6 | 9 | 4 |
| Days Payable | 194 | 123 | 240 | 295 | 250 | 303 | 129 | |||
| Cash Conversion Cycle | 144 | 74 | 30 | 90 | 43 | 471 | 173 | -168 | -255 | -110 |
| Working Capital Days | 58 | 43 | 53 | 41 | 32 | 255 | 184 | 91 | 77 | 99 |
| ROCE % | 31% | 29% | 28% | 20% | 30% | 17% | 19% | 24% | 27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.68 | 6.24 | 5.84 | 4.61 | 8.43 |
| Diluted EPS (Rs.) | 8.68 | 6.24 | 5.84 | 4.61 | 8.43 |
| Cash EPS (Rs.) | 14.08 | 9.86 | 6.63 | 5.44 | 10.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 66.70 | 47.51 | 39.89 | 34.04 | 29.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 66.70 | 47.51 | 39.89 | 34.04 | 29.43 |
| Revenue From Operations / Share (Rs.) | 142.70 | 106.02 | 76.50 | 51.69 | 45.09 |
| PBDIT / Share (Rs.) | 24.29 | 18.14 | 13.22 | 11.36 | 18.19 |
| PBIT / Share (Rs.) | 23.14 | 17.05 | 12.44 | 10.53 | 16.28 |
| PBT / Share (Rs.) | 19.58 | 12.81 | 7.92 | 6.34 | 11.56 |
| Net Profit / Share (Rs.) | 12.93 | 8.77 | 5.84 | 4.61 | 8.46 |
| NP After MI And SOA / Share (Rs.) | 8.73 | 6.24 | 5.83 | 4.61 | 8.43 |
| PBDIT Margin (%) | 17.02 | 17.11 | 17.28 | 21.97 | 40.33 |
| PBIT Margin (%) | 16.21 | 16.08 | 16.25 | 20.37 | 36.10 |
| PBT Margin (%) | 13.71 | 12.08 | 10.35 | 12.27 | 25.62 |
| Net Profit Margin (%) | 9.06 | 8.27 | 7.63 | 8.92 | 18.75 |
| NP After MI And SOA Margin (%) | 6.11 | 5.88 | 7.62 | 8.91 | 18.70 |
| Return on Networth / Equity (%) | 13.08 | 13.63 | 14.66 | 13.57 | 28.74 |
| Return on Capital Employeed (%) | 26.44 | 29.31 | 24.29 | 20.16 | 31.34 |
| Return On Assets (%) | 5.57 | 5.11 | 5.33 | 4.68 | 7.88 |
| Long Term Debt / Equity (X) | 0.06 | 0.02 | 0.05 | 0.20 | 0.33 |
| Total Debt / Equity (X) | 0.43 | 0.62 | 0.73 | 0.86 | 1.19 |
| Asset Turnover Ratio (%) | 1.05 | 0.91 | 0.73 | 0.50 | 0.46 |
| Current Ratio (X) | 1.73 | 1.49 | 1.47 | 1.77 | 1.63 |
| Quick Ratio (X) | 1.71 | 1.48 | 1.47 | 1.77 | 1.17 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.43 | 0.30 |
| Interest Coverage Ratio (X) | 6.81 | 4.29 | 2.93 | 2.71 | 3.85 |
| Interest Coverage Ratio (Post Tax) (X) | 4.63 | 3.07 | 2.29 | 2.10 | 2.79 |
| Enterprise Value (Cr.) | 268.58 | 182.49 | 127.18 | 125.37 | 79.24 |
| EV / Net Operating Revenue (X) | 1.65 | 1.51 | 1.46 | 2.13 | 1.55 |
| EV / EBITDA (X) | 9.68 | 8.85 | 8.46 | 9.71 | 3.83 |
| MarketCap / Net Operating Revenue (X) | 1.49 | 1.31 | 1.12 | 1.64 | 0.84 |
| Price / BV (X) | 3.19 | 3.04 | 2.16 | 2.50 | 1.30 |
| Price / Net Operating Revenue (X) | 1.49 | 1.31 | 1.12 | 1.64 | 0.84 |
| EarningsYield | 0.04 | 0.04 | 0.06 | 0.05 | 0.22 |
After reviewing the key financial ratios for Univastu India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 8.68, marking an increase of 2.44.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.68. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 8.68, marking an increase of 2.44.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.08. This value is within the healthy range. It has increased from 9.86 (Mar 24) to 14.08, marking an increase of 4.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.70. It has increased from 47.51 (Mar 24) to 66.70, marking an increase of 19.19.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.70. It has increased from 47.51 (Mar 24) to 66.70, marking an increase of 19.19.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.70. It has increased from 106.02 (Mar 24) to 142.70, marking an increase of 36.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 24.29. This value is within the healthy range. It has increased from 18.14 (Mar 24) to 24.29, marking an increase of 6.15.
- For PBIT / Share (Rs.), as of Mar 25, the value is 23.14. This value is within the healthy range. It has increased from 17.05 (Mar 24) to 23.14, marking an increase of 6.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 19.58. This value is within the healthy range. It has increased from 12.81 (Mar 24) to 19.58, marking an increase of 6.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.93. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 12.93, marking an increase of 4.16.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.73. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 8.73, marking an increase of 2.49.
- For PBDIT Margin (%), as of Mar 25, the value is 17.02. This value is within the healthy range. It has decreased from 17.11 (Mar 24) to 17.02, marking a decrease of 0.09.
- For PBIT Margin (%), as of Mar 25, the value is 16.21. This value is within the healthy range. It has increased from 16.08 (Mar 24) to 16.21, marking an increase of 0.13.
- For PBT Margin (%), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 12.08 (Mar 24) to 13.71, marking an increase of 1.63.
- For Net Profit Margin (%), as of Mar 25, the value is 9.06. This value is within the healthy range. It has increased from 8.27 (Mar 24) to 9.06, marking an increase of 0.79.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.11. This value is below the healthy minimum of 8. It has increased from 5.88 (Mar 24) to 6.11, marking an increase of 0.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.08. This value is below the healthy minimum of 15. It has decreased from 13.63 (Mar 24) to 13.08, marking a decrease of 0.55.
- For Return on Capital Employeed (%), as of Mar 25, the value is 26.44. This value is within the healthy range. It has decreased from 29.31 (Mar 24) to 26.44, marking a decrease of 2.87.
- For Return On Assets (%), as of Mar 25, the value is 5.57. This value is within the healthy range. It has increased from 5.11 (Mar 24) to 5.57, marking an increase of 0.46.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.06, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.43, marking a decrease of 0.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.05. It has increased from 0.91 (Mar 24) to 1.05, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.49 (Mar 24) to 1.73, marking an increase of 0.24.
- For Quick Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has increased from 1.48 (Mar 24) to 1.71, marking an increase of 0.23.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.81. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 6.81, marking an increase of 2.52.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.63. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 4.63, marking an increase of 1.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 268.58. It has increased from 182.49 (Mar 24) to 268.58, marking an increase of 86.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.65, marking an increase of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 9.68. This value is within the healthy range. It has increased from 8.85 (Mar 24) to 9.68, marking an increase of 0.83.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.49, marking an increase of 0.18.
- For Price / BV (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has increased from 3.04 (Mar 24) to 3.19, marking an increase of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.49, marking an increase of 0.18.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Univastu India Ltd:
- Net Profit Margin: 9.06%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 26.44% (Industry Average ROCE: 16.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.08% (Industry Average ROE: 21.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.63
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18 (Industry average Stock P/E: 91.06)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.06%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | Bunglow No 36/B, C.T.S. No 994 & 945 (S.No.117 & 118), Pune Maharashtra 411038 | cs@univastu.com http://www.univastu.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradeep Khandagale | Chairman & Managing Director |
| Mr. Narendra Bhagatkar | Executive Director |
| Maj. Gen. (Dr.) Vijay Pawar | Independent Director |
| Mr. Ravindra Savant | Independent Director |
| Mr. Dhananjay Barve | Independent Director |
| Mrs. Rajashri Khandagale | Non Executive Director |